Poolbeg Pharma has dosed the first patient in a clinical [...]

InduPro has licensed Lonza’s antibody-drug conjugate technologies to support development [...]

Poolbeg Pharma has presented two posters at the European Hematology [...]

Lonza has expanded its integrated DNA-to-IND biologics development offering, introducing [...]

Laigo Bio has completed a €17 million seed financing round [...]

Expanded partnership includes new clinical trial and third SAFEbody discovery [...]

Poland-based CDMO Mabion has completed the first GMP-compliant batch of [...]

Axio BioPharma and Likarda have announced a strategic collaboration designed [...]

Poolbeg Pharma has been granted Orphan Drug Designation (ODD) by [...]